Agios Agios Pharmaceuticals is a biopharmaceutical company
dedicated to the development of novel therapeutics
in the emerging field of cancer metabolism, which
represents a breakthrough understanding of how
cancer cells adapt to use more nutrients than normal
cells to promote their survival and growth. Agios’
primary focus is in oncology, but the company’s
platform will also be applicable to other
therapeutics areas including including
obesity/diabetes, autoimmune, inflammatory and
neurological diseases.
Constellation Constellation Pharmaceuticals is a
biopharmaceutical
company dedicated to the development of novel
therapeutics
in the emerging field of Epigenetics, a new field of
science which is focused on selective regulators of
epigenetic function,
which are critical to controlling gene function and
expression. Constellation will initially focus on
developing novel therapeutics in oncology, but the
company's platform is broadly applicable
to other therapeutic areas including autoimmune,
inflammatory and neurological diseases.
Zafgen Zafgen is a biopharmaceutical company dedicated to
the development of novel therapeutics to treat
obesity based
on the vascular targeting of adipose
tissue.
